Rokit Healthcare receives certification under CEMDR for 'Dr Invivo AI Regen Platform'
Positive Phase 2, Proof-of-Concept Results for VX-548 Published in New England Journal of Medicine
PharmAbcine doses first patient in phase one PMC-403 clinical trial
GlucoTrack reports positive data from feasibility study for implantable continuous glucose monitor
SomaLogic forms alliance with Dante Genomics to advance proteomics testing in Europe
Genprex signs exclusive license agreement with the University of Pittsburgh
Brenzavvy Now Available for the Treatment of Adults with Type 2 Diabetes
Novartis receives FDA approval for Leqvio (inclisiran) label update
European Patent granted for ZyVersa Therapeutics' VAR 200, targeting diabetic nephropathy
Health Canada approves Dexcom G7: next-generation Continuous Glucose Monitoring System for Canadians
Dexcom G7 continuous glucose monitoring system receives Health Canada approval